Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome

Some, but not all, intravenous iron formulations have been recognized to induce renal phosphate wasting syndrome. Most commonly this has been reported following treatment of iron deficiency anemia (IDA) with ferric carboxymaltose (FCM). A search of PubMed identified relevant randomized controlled tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Glaspy, John A., Wolf, Myles, Strauss, William E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279965/
https://www.ncbi.nlm.nih.gov/pubmed/34053011
http://dx.doi.org/10.1007/s12325-021-01770-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279965/
https://www.ncbi.nlm.nih.gov/pubmed/34053011
http://dx.doi.org/10.1007/s12325-021-01770-2

Ejemplares similares